Published April 22, 2022 | Version v1
Dataset Open

Immune and genetic signature of HER2-driven breast carcinomas triggering anti-Yo paraneoplastic cerebellar degeneration

  • 1. Synaptopathies and Autoantibodies (SynatAc) Team, Institut NeuroMyoGène-MeLis, INSERM U1314/CNRS UMR 5284, Université de Lyon, Lyon, France; French Reference Center on Paraneoplastic Neurological Syndrome, Hospices Civils de Lyon, Lyon, France; University of Lyon, Université Claude Bernard Lyon 1, Lyon, France

Description

  • Supplementary eTables from: Immune and genetic signature of HER2-driven breast carcinomas triggering anti-Yo paraneoplastic cerebellar degeneration:
    • eTables 1: Results of DESeq2 on the differential gene expression analysis between Yo-PCD and control tumours for all genes and for differentially expressed genes.
    • eTables 2: Results of the Gene Ontology enrichment performed by clusterProfiler on genes over-expressed in Yo-PCD tumours
    • eTables 3: Results of the Gene Ontology enrichment performed by clusterProfiler on genes under-expressed in Yo-PCD tumours
  • Gene counts
  • Gene TPMs

Files

Files (12.3 MB)

Name Size Download all
md5:2ce8f58293184d0d6884f32bb4a969a4
1.6 MB Download
md5:eaee7b6d05cf28234397c3abca0b5a64
24.3 kB Download
md5:493ad8b93be7b1db78a95a19c389c321
6.6 kB Download
md5:709af2a9a75ff1b9bae019936229fe63
4.9 MB Download
md5:0c64bed4085b56ba068749b4ef3150bc
5.7 MB Download

Additional details

Funding

BETPSY – Biomarkers in autoimmune EncephaliTis and Paraneoplastic neurological SYndromes ANR-18-RHUS-0012
Agence Nationale de la Recherche